RaySearch Laboratories AB (OSTO:RAY B) Change In Receivables : kr-9 Mil (TTM As of Mar. 2024)

View and export this data going back to 1991. Start your Free Trial

What is RaySearch Laboratories AB Change In Receivables?

RaySearch Laboratories AB's change in receivables for the quarter that ended in Mar. 2024 was kr12 Mil. It means RaySearch Laboratories AB's Accounts Receivable declined by kr12 Mil from Dec. 2023 to Mar. 2024 .

RaySearch Laboratories AB's change in receivables for the fiscal year that ended in Dec. 2023 was kr32 Mil. It means RaySearch Laboratories AB's Accounts Receivable declined by kr32 Mil from Dec. 2022 to Dec. 2023 .

RaySearch Laboratories AB's Accounts Receivable for the quarter that ended in Mar. 2024 was kr250 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. RaySearch Laboratories AB's Days Sales Outstanding for the three months ended in Mar. 2024 was 88.84.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. RaySearch Laboratories AB's liquidation value for the three months ended in Mar. 2024 was kr-652 Mil.

RaySearch Laboratories AB Change In Receivables Historical Data

The historical data trend for RaySearch Laboratories AB's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RaySearch Laboratories AB Change In Receivables Chart

RaySearch Laboratories AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

45.34

52.15

17.05

-66.04

31.78

RaySearch Laboratories AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															52.73	-19.53	19.12	-20.54	11.59

RaySearch Laboratories AB Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-9 Mil.

RaySearch Laboratories AB (OSTO:RAY B) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

RaySearch Laboratories AB's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	250.398	/	257.196	*	91
=	88.84

2. In Ben Graham's calculation of liquidation value, RaySearch Laboratories AB's accounts receivable are only considered to be worth 75% of book value:

RaySearch Laboratories AB's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	440.131	-	1287.656	+	0.75 * 250.398	+	0.5 * 14.518
=	-652

RaySearch Laboratories AB Change In Receivables Related Terms

Thank you for viewing the detailed overview of RaySearch Laboratories AB's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

RaySearch Laboratories AB (OSTO:RAY B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » RaySearch Laboratories AB (OSTO:RAY B) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

RSLBF:USA 0GRZ:UK 27R:Germany

Address

Sveavagen 44, P.O. Box 3297, Stockholm, SWE, 103 65

Website

https://www.raysearchlabs.com

RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia, Europe and the rest of the world. The company generates majority of its sales from the North America.

RaySearch Laboratories AB (OSTO:RAY B) Headlines

No Headlines